Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$588M |
| 2 |
UnitedHealth
UNH
|
+$429M |
| 3 |
Johnson & Johnson
JNJ
|
+$333M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXE
Expand Energy Corp
EXE
|
+$322M |
| 2 |
JPMorgan Chase
JPM
|
+$304M |
| 3 |
K
Kellanova
K
|
+$164M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$156M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Financials | 18.7% |
| 3 | Industrials | 12.07% |
| 4 | Healthcare | 10.44% |
| 5 | Consumer Discretionary | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Actinium Pharmaceuticals
ATNM
$26.3M
| $56.2K | ﹤0.01% |
34,923
| – | – |
|
3252
Rapid Micro Biosystems
RPID
$106M
| $55.9K | ﹤0.01% |
+21,167
| New | +$48.3K |
|
|
SGMA
3253
DELISTED
Sigmatron International
SGMA
| $53.8K | ﹤0.01% |
43,052
-18,211
| -30% | -$27K |
|
3254
Ideal Power
IPWR
$60.8M
| $53.6K | ﹤0.01% |
+10,311
| New | +$64.7K |
|
|
SGMO
3255
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $52.8K | ﹤0.01% |
80,584
-3,686
| -4% | -$3.9K |
|
|
BGFV
3256
DELISTED
Big 5 Sporting Goods
BGFV
| $52.8K | ﹤0.01% |
54,593
-64,787
| -54% | -$88.7K |
|
|
ZYXI
3257
DELISTED
Zynex
ZYXI
| $52.7K | ﹤0.01% |
23,932
+4,599
| +24% | +$30K |
|
|
ENZ
3258
DELISTED
Enzo Biochem, Inc.
ENZ
| $51.5K | ﹤0.01% |
138,126
-157,551
| -53% | -$87K |
|
|
LITS
3259
Lite Strategy Inc
LITS
$32.8M
| $51.3K | ﹤0.01% |
23,427
| – | – |
|
|
IMA
3260
ImageneBio Inc
IMA
$63M
| $49.5K | ﹤0.01% |
3,218
| – | – |
|
|
NBP
3261
NovaBridge Biosciences American Depositary Shares
NBP
$185M
| $48.1K | ﹤0.01% |
58,358
| – | – |
|
3262
Acumen Pharmaceuticals
ABOS
$155M
| $47.9K | ﹤0.01% |
43,524
-54,492
| -56% | -$77.8K |
|
3263
Sono-Tek
SOTK
$81.3M
| $46.4K | ﹤0.01% |
12,737
| – | – |
|
3264
Aterian
ATER
$4.45M
| $45.7K | ﹤0.01% |
21,778
| – | – |
|
3265
VistaGen Therapeutics
VTGN
$9.89M
| $43.9K | ﹤0.01% |
+17,545
| New | +$49.7K |
|
|
ASRT
3266
DELISTED
Assertio
ASRT
| $43.1K | ﹤0.01% |
4,256
-31
| -0.7% | -$370 |
|
|
NVNO
3267
enVVeno Medical
NVNO
$7.08M
| $42.4K | ﹤0.01% |
461
-3
| -0.6% | -$334 |
|
3268
Butterfly Network
BFLY
$1.89B
| $41.9K | ﹤0.01% |
18,247
| – | – |
|
3269
Tenaya Therapeutics
TNYA
$161M
| $41.8K | ﹤0.01% |
73,408
-24,573
| -25% | -$24.2K |
|
3270
ImmunityBio
IBRX
$7.51B
| $40.1K | ﹤0.01% |
13,328
-14,638
| -52% | -$44.4K |
|
3271
Comstock
LODE
$208M
| $39.7K | ﹤0.01% |
+16,277
| New | +$54.1K |
|
3272
AlTi Global
ALTI
$399M
| $39.5K | ﹤0.01% |
12,985
+2,909
| +29% | +$10.4K |
|
3273
Blink Charging
BLNK
$74.3M
| $39.3K | ﹤0.01% |
42,819
-14,032
| -25% | -$16.2K |
|
3274
TechPrecision Corp
TPCS
$47.3M
| $39.2K | ﹤0.01% |
+17,026
| New | +$50K |
|
|
FORA
3275
DELISTED
Forian
FORA
| $36.3K | ﹤0.01% |
18,143
+2,551
| +16% | +$5.69K |
|
Similar funds
Dimensional Fund Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Dimensional Fund Advisors held 3,398 positions worth $402B, down 3.4% from $416B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4%. Dimensional Fund Advisors opened 59 new positions and exited 78, leaving the 3,398-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2025 buy was Sandisk: 849,963 shares worth $40.5M.
- Dimensional Fund Advisors added most to Apple in Q1 2025, an estimated $588M increase.
- Dimensional Fund Advisors's biggest Q1 2025 reduction was Expand Energy Corp, cutting an estimated $322M.
- Dimensional Fund Advisors fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $159M.
- Dimensional Fund Advisors's ten largest holdings make up 15% of its $402B portfolio in Q1 2025.
- Dimensional Fund Advisors opened 59 new positions and closed 78 in Q1 2025.
- Dimensional Fund Advisors's portfolio value fell 3.4% quarter-over-quarter to $402B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2025, filed 13 May 2025.